We are ProQR, a biotechnology company dedicated to changing lives by developing RNA therapies for severe rare and common diseases. We focus on advancing our proprietary Axiomer™ RNA-editing platform technology. ProQR has offices in Leiden, the Netherlands and Cambridge, Massachusetts, USA.
Learn more about RNA therapy and our Axiomer technology.
From the day our company was founded in 2012, our mission has been to help people living with rare diseases that currently have no treatment options. This remains an important focus of our company today.
Read more about our Founding story.
In order to achieve our goals, ProQR strives to integrate the patient voice into our decision-making throughout the drug development process as we believe that a patient-focused strategy is crucial to our success.
